Trials / Unknown
UnknownNCT02016859
Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Dr. Yishai Ofran · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that this value may be another prognostic factor in critically ill patients such as those admitted to ICU, or those with neutropenic Fever. The purpose of the study is to check if the IPF may be used as a prognostic Factor in these patients
Detailed description
In this study we have 3 groups of patients * Patients admitted to ICU * Patients admitted with neutropenic fever * Patients admitted with hip fractures it is a prospective study, not interventional, we'll take blood samples of these patients including CBC count eith IPF and other inflammation markers such as CRP and we'll compare CRP to IPF in addition to clinical follow-up of the patient till discharge. At the end of this study we'll compare the efficacy of IPF as a prognostic Factor in these patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Immature Platelet Fraction |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-05-01
- Completion
- 2014-11-01
- First posted
- 2013-12-20
- Last updated
- 2013-12-20
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02016859. Inclusion in this directory is not an endorsement.